Announcement on Results of Shareholding Reduction by Director and Senior Executive
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(603811)"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Results of Shareholding Reduction by Director and Senior Executive
Filed with SSE · Stock code 603811 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Zhejiang Chengyi Pharmaceutical Co. Ltd. on 6ix
Story so far
Earlier from Zhejiang Chengyi Pharmaceutical
- Announcement on Results of Shareholding Reduction by Senior Executive
- Announcement on a Subsidiary's Receipt of Drug GMP Compliance Inspection Results
- Announcement on Outline of the 2026 Semi-annual Performance Briefing
- Announcement on Satisfaction of Unlocking Conditions for the 1st Unlocking Period under the 2025 Employee Stock Ownership Plan
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow Zhejiang Chengyi Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Chengyi Pharmaceutical